Switching hemophilia A patients to rVIII-SingleChain: The Iberian experience

The real-world outcomes of lonoctocog alfa (rVIII-SingleChain), a long-acting factor VIII (FVIII) with a favorable safety and efficacy profile in trials, were assessed in patients with hemophilia A in Iberian (Spain and Portugal). This was a retrospective study involving patients switching to rVIII-...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Medicine (Baltimore) 2024-09, Vol.103 (36), p.e39255
Hauptverfasser:	Calvo-Villas, José Manuel, Núñez-Vázquez, Ramiro, Benítez-Hidalgo, Olga, García-Díaz, Covadonga, Galmés, Bernat, Carvalho, Manuela, Serrano-Torres, Pilar, Aznar-Salatti, José, Álvarez-Román, María Teresa
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Child Drug Substitution Factor VIII - administration & dosage Factor VIII - therapeutic use Female Hemophilia A - drug therapy Hemorrhage Humans Male Middle Aged Observational Study Portugal Retrospective Studies Spain Treatment Outcome Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!